Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

April 17, 2018 - 5:02 p.m.
Gilead Sciences to Release First Quarter 2018 Financial Results on Tuesday, May 1, 2018Printer Friendly Version 
April 13, 2018 - 10:15 a.m.
Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis at The International Liver Congress™ 2018Printer Friendly Version 

Upcoming Events

Tuesday, May 1, 2018 1:30 p.m. PT
First Quarter 2018 Gilead Sciences Earnings Conference Call
Wednesday, May 9, 2018 10:00 a.m. PT
2018 Annual Meeting of Stockholders
LocationMillbrae, CA

Most Viewed Links

Updated 04/26/18
1.SEC Filings
2.Annual Reports
4.Proxy Online
5.Fundamentals - Snapshot
* Data collected 04/18/18 - 04/25/18

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Up 0.84 (1.15%)
Data as of 04/26/18 2:51 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at the RBC Capital Markets 2018 Global Healthcare Conference

February 21, 2018 9:00 a.m. ET
Fourth Quarter 2017 Gilead Sciences Earnings Conference Call

February 06, 2018 4:30 p.m. ET
36th Annual J.P. Morgan Healthcare Conference

January 08, 2018 3:30 p.m. PT
Credit Suisse 26th Annual Healthcare Conference

November 07, 2017 12:30 p.m. MT